Crestchem Limited is an Indian specialty chemical company focused on the processing, manufacturing, and marketing of high-value **Nutrition-Chemical Products**. Operating as a standalone entity without subsidiaries, the company has transitioned from a period of resource conservation to an active growth phase, characterized by a **debt-free balance sheet**, expanding net worth, and the commencement of dividend payments. --- ### **Core Product Portfolio & Specialized Manufacturing** Crestchem operates within a single reportable segment: **Nutrition-Speciality Chemical Industries**. The company has carved a niche in the production of medium-chain fatty acid derivatives, which are essential in the pharmaceutical, nutraceutical, and food industries. * **Primary Product Line:** **Caprylic / Capric Triglycerides (MCT)**. * **Product Forms:** Manufactured in both **oil and powder forms** to cater to diverse industrial applications. * **Downstream Integration:** The company develops various downstream products derived from MCTs, utilized for specialized nutritional and industrial applications. * **Infrastructure:** Operations are centralized at a single manufacturing facility in **Indrad, Mehsana (Gujarat)**, supported by a corporate office in **Ahmedabad**. The facility is strategically located in a chemical-industrial hub, providing access to necessary logistics and labor. --- ### **Strategic Growth: Innovation & LLP Expansion Model** The company is currently executing a strategic shift toward scaling its presence in the **Specialty Chemicals** sector through a unique partnership-driven expansion model. * **LLP Investment Strategy:** Crestchem plans to invest in and expand through **Limited Liability Partnership (LLP)** firms. This allows for flexible operational scaling while maintaining focus on the core specialty chemicals field. * **Pilot Plant Development:** To facilitate the launch of new products, the company is establishing pilot plant facilities within these LLP firms. * **R&D Collaboration:** Crestchem previously assigned project work to a **CSIR (Council of Scientific and Industrial Research)** entity, leveraging national-level technical expertise to refine its manufacturing processes. * **Technical & Managerial Support:** The company’s growth strategy involves providing technical know-how, managerial oversight, and financial assistance to these new ventures. * **Timeline:** Management anticipates the establishment of pilot plant operations during **FY 2025-26** or shortly thereafter. --- ### **Financial Performance & Capital Structure** Crestchem has demonstrated a robust financial recovery, moving from a period of carrying forward losses to substantial profitability and a strengthened equity base. **Three-Year Net Worth Growth** | Financial Year Ended | Paid-up Share Capital (INR) | Net Worth (INR) | | :--- | :--- | :--- | | **31st March 2025** | **Rs. 3,00,00,000** | **Rs. 7,47,59,717** | | **31st March 2024** | **Rs. 3,00,00,000** | **Rs. 4,89,94,971** | | **31st March 2023** | **Rs. 3,00,00,000** | **Rs. 2,75,31,620** | **Key Financial Highlights:** * **Solvency:** The company is **debt-free** with no outstanding borrowings from banks or financial institutions. * **Liquidity:** While the company utilizes **FD-OD facilities** (Overdraft against its own Fixed Deposits) for routine working capital, these are short-term and cleared regularly. * **Dividend Policy:** Reflecting improved cash flows, the Board recommended a **10% dividend (Rs. 1/- per share)** for **FY 2024-25**, following a **5% maiden dividend** in **FY 2023-24**. * **Public Deposits:** The company has **not invited any public deposits** under Sections 73 to 76 of the Companies Act, 2013. --- ### **Governance, Leadership & Shareholding** The company is led by a board with deep technical and financial expertise, recently restructured to align with long-term growth objectives. * **Executive Leadership:** * **Shri Dipak N. Patel (Chairman & MD):** Over **30 years** of industry experience. His tenure is approved until **September 30, 2026**, with a monthly salary of up to **Rs. 5,00,000 plus perquisites**. * **Shri Nirmit D. Patel (Executive Director):** Reappointed for the **2026-2031** term, ensuring leadership continuity. * **Board Oversight:** Includes **Shri Jignesh A. Shah**, an Independent Director appointed for a five-year term ending in **2029**, specializing in finance and risk management. * **Shareholding Dynamics:** * **Promoter Holding:** Approximately **28.46%** (as of March 2024). * **Reclassification:** In **May 2025**, the company received approval to reclassify **86,473 shares (2.88%)** from 'Promoter Group' to the **'Public'** category. * **Dematerialization:** **46.01%** of the **3,000,000** total equity shares are held in dematerialized form. --- ### **Risk Profile & Mitigation Strategies** Crestchem manages a complex risk environment ranging from high customer concentration to evolving national fuel policies. **1. Concentration & Market Risks** * **Revenue Concentration:** A critical risk factor is the company’s reliance on a single major customer, who accounted for **98.29%** of total revenue in FY24 (and **97.132%** or **Rs. 243,011.06 thousand** in the subsequent period). * **Credit Risk:** Managed through **individual credit limits** and ratings, though the company does not typically hold **collateral** for trade receivables. **2. Regulatory & Legal Risks** * **Statutory Litigation:** The company is contesting a complaint by the **ROC, Gujarat** (Criminal Case No: **0035137/2022**) regarding the alleged non-filing of the **Secretarial Audit Report** for **FY 2016-17**. The company has filed a **discharge application**, asserting compliance. * **Ethanol Blending (E20) Impact:** The national mandate to blend **20% ethanol** in petrol has caused localized technical issues in storage tanks (separation of fluids), leading to potential supply chain friction in coastal regions like **Surat**. **3. Operational & Macro Risks** * **Supply Chain:** Exposure to international disturbances (e.g., Ukraine war effects) is mitigated through **superior cost-effective technologies** and agile procurement. * **Compliance:** The company adheres to **Ind AS**, **GST**, and **Contract Labour Laws**. It is currently exempt from mandatory Corporate Governance reporting under **SEBI (LODR)** as its paid-up capital is below **Rs. 10 Crore** and net worth is below **Rs. 25 Crore**. **Risk Mitigation Summary Table** | Risk Category | Mitigation Strategy | | :--- | :--- | | **Technical Obsolescence** | Investment in pilot plants and CSIR-backed project work. | | **Asset Loss** | Comprehensive insurance of all physical assets and human capital. | | **Liquidity Risk** | Strategic planning and utilization of FD-backed credit lines. | | **Insider Trading** | Strict adherence to **trading window closures** for designated persons. | | **Industrial Relations** | Maintaining **harmonious and cordial** relations with the workforce. |